VDR and colorectal cancer: Genome-wide screening using non-prostate cell lines (immune cells and colorectal cancer cells) recently identified over 10,000 new VDR-binding sites (107), and many cytokines, cytokine receptors, and other immune-related genes were identified as VDR targets (108–110).